期刊
CELL DEATH AND DIFFERENTIATION
卷 19, 期 3, 页码 416-427出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2011.105
关键词
lanosterol; Parkinson's disease; mitochondrial membrane potential; lipids; dopaminergic neruons
资金
- National University of Singapore (NUS), Department of Biological Sciences
- Singapore Biomedical Research Council (BMRC) [ID 08/1/21/19/558]
- Singapore National Research Foundation under CRP [2007-04]
- SystemsX.ch RTD project LipidX
Parkinson's disease (PD) is a neurodegenerative disorder marked by the selective degeneration of dopaminergic neurons in the nigrostriatal pathway. Several lines of evidence indicate that mitochondrial dysfunction contributes to its etiology. Other studies have suggested that alterations in sterol homeostasis correlate with increased risk for PD. Whether these observations are functionally related is, however, unknown. In this study, we used a toxin-induced mouse model of PD and measured levels of nine sterol intermediates. We found that lanosterol is significantly (similar to 50%) and specifically reduced in the nigrostriatal regions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, indicative of altered lanosterol metabolism during PD pathogenesis. Remarkably, exogenous addition of lanosterol rescued dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+)-induced cell death in culture. Furthermore, we observed a marked redistribution of lanosterol synthase from the endoplasmic reticulum to mitochondria in dopaminergic neurons exposed to MPP+, suggesting that lanosterol might exert its survival effect by regulating mitochondrial function. Consistent with this model, we find that lanosterol induces mild depolarization of mitochondria and promotes autophagy. Collectively, our results highlight a novel sterol-based neuroprotective mechanism with direct relevance to PD. Cell Death and Differentiation (2012) 19, 416-427; doi: 10.1038/cdd.2011.105; published online 5 August 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据